Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ITCI - Intra-Cellular Therapies GAAP EPS of -$0.45 beats by $0.15 revenue of $87.87M beats by $0.9M


ITCI - Intra-Cellular Therapies GAAP EPS of -$0.45 beats by $0.15 revenue of $87.87M beats by $0.9M

  • Intra-Cellular Therapies press release ( NASDAQ: ITCI ): Q4 GAAP EPS of -$0.45 beats by $0.15 .
  • Revenue of $87.87M (+242.3% Y/Y) beats by $0.9M .
  • CEO comment: "We expect 2023 to be another year of significant growth for CAPLYTA and the company.”
  • CAPLYTA 2023 net product sales are expected to be $430 to $455 million.

For further details see:

Intra-Cellular Therapies GAAP EPS of -$0.45 beats by $0.15, revenue of $87.87M beats by $0.9M
Stock Information

Company Name: Intra-Cellular Therapies Inc.
Stock Symbol: ITCI
Market: NASDAQ
Website: intracellulartherapies.com

Menu

ITCI ITCI Quote ITCI Short ITCI News ITCI Articles ITCI Message Board
Get ITCI Alerts

News, Short Squeeze, Breakout and More Instantly...